Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study
- Resource Type
- Article
- Source
- In
European Journal of Internal Medicine February 2021 84:63-67 - Subject
- Language
- ISSN
- 0953-6205